ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Standard Nuclear shares jump 19% on IPO momentum, analyst upgrades

Stock approaches five-year high as Goldman Sachs and William Blair initiate coverage with bullish ratings and price targets above current levels.

PA
Priya Anand · Equities & Earnings Desk · 30 Aug 2026 · 02:03 · 1 min read
Share
Standard Nuclear shares jump 19% on IPO momentum, analyst upgrades

Standard Nuclear Inc. surged 19.4% in midday trading on Tuesday, lifting shares to within striking distance of their five-year high of $15.00, set at the company’s IPO pricing in July.

The advance extended gains from the stock’s July listing, coinciding with broader market strength as the S&P 500 and Nasdaq traded higher. The company is scheduled to release second-quarter 2026 earnings after the market close on Wednesday, followed by an analyst and investor conference call on Thursday morning.

Goldman Sachs initiated coverage with a Buy rating and an $18 price target, while William Blair launched coverage with an Outperform rating and a $20 fair value estimate. Evercore ISI, Barclays, BofA, UBS, and Stifel also joined with positive ratings, assigning price targets ranging from $14 to $20.

Standard Nuclear positions itself as the only U.S. company with industrial-scale TRISO nuclear fuel manufacturing capability. The company is involved in government-backed advanced reactor and military microreactor programs, and is commissioning two new TRISO production facilities—SN-TN and SN-ID—both of which have received safety approvals from the U.S. Department of Energy.

The stock’s rally follows a period of heightened interest in nuclear energy-related equities amid policy support and long-term decarbonization trends.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT